313 related articles for article (PubMed ID: 38516408)
1. ERCC4: a potential regulatory factor in inflammatory bowel disease and inflammation-associated colorectal cancer.
Shi R; Wang S; Jiang Y; Zhong G; Li M; Sun Y
Front Endocrinol (Lausanne); 2024; 15():1348216. PubMed ID: 38516408
[TBL] [Abstract][Full Text] [Related]
2. DNA damage response genes mark the early transition from colitis to neoplasia in colitis-associated colon cancer.
Sharp SP; Malizia RA; Walrath T; D'Souza SS; Booth CJ; Kartchner BJ; Lee EC; Stain SC; O'Connor W
Gene; 2018 Nov; 677():299-307. PubMed ID: 30121380
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory bowel disease and carcinogenesis.
Nagao-Kitamoto H; Kitamoto S; Kamada N
Cancer Metastasis Rev; 2022 Jun; 41(2):301-316. PubMed ID: 35416564
[TBL] [Abstract][Full Text] [Related]
4. Molecular Pathogenesis of Colitis-associated Colorectal Cancer: Immunity, Genetics, and Intestinal Microecology.
Yin Y; Wan J; Yu J; Wu K
Inflamm Bowel Dis; 2023 Oct; 29(10):1648-1657. PubMed ID: 37202830
[TBL] [Abstract][Full Text] [Related]
5. From Inflammation to Cancer in Inflammatory Bowel Disease: Molecular Perspectives.
Romano M; DE Francesco F; Zarantonello L; Ruffolo C; Ferraro GA; Zanus G; Giordano A; Bassi N; Cillo U
Anticancer Res; 2016 Apr; 36(4):1447-60. PubMed ID: 27069120
[TBL] [Abstract][Full Text] [Related]
6. Inter-individual variation in nucleotide excision repair pathway is modulated by non-synonymous polymorphisms in ERCC4 and MBD4 genes.
Allione A; Guarrera S; Russo A; Ricceri F; Purohit R; Pagnani A; Rosa F; Polidoro S; Voglino F; Matullo G
Mutat Res; 2013; 751-752():49-54. PubMed ID: 24004570
[TBL] [Abstract][Full Text] [Related]
7. ERCC4 (XPF) encodes a human nucleotide excision repair protein with eukaryotic recombination homologs.
Brookman KW; Lamerdin JE; Thelen MP; Hwang M; Reardon JT; Sancar A; Zhou ZQ; Walter CA; Parris CN; Thompson LH
Mol Cell Biol; 1996 Nov; 16(11):6553-62. PubMed ID: 8887684
[TBL] [Abstract][Full Text] [Related]
8. Retinoid acid induced 16 deficiency aggravates colitis and colitis-associated tumorigenesis in mice.
Xu YL; Ding CL; Qian CL; Qi ZT; Wang W
Cell Death Dis; 2019 Dec; 10(12):958. PubMed ID: 31862898
[TBL] [Abstract][Full Text] [Related]
9. The Differential Expression of Core Genes in Nucleotide Excision Repair Pathway Indicates Colorectal Carcinogenesis and Prognosis.
Liu J; Li H; Sun L; Feng X; Wang Z; Yuan Y; Xing C
Biomed Res Int; 2018; 2018():9651320. PubMed ID: 29568775
[TBL] [Abstract][Full Text] [Related]
10. Regulation of MicroRNAs in Inflammation-Associated Colorectal Cancer: A Mechanistic Approach.
Muthusami S; Ramachandran I; Krishnamoorthy S; Sambandam Y; Ramalingam S; Queimado L; Chaudhuri G; Ramachandran IK
Endocr Metab Immune Disord Drug Targets; 2021; 21(1):67-76. PubMed ID: 32940190
[TBL] [Abstract][Full Text] [Related]
11. Distinct clinicohistologic features of inflammatory bowel disease-associated colorectal adenocarcinoma: in comparison with sporadic microsatellite-stable and Lynch syndrome-related colorectal adenocarcinoma.
Liu X; Goldblum JR; Zhao Z; Landau M; Heald B; Pai R; Lin J
Am J Surg Pathol; 2012 Aug; 36(8):1228-33. PubMed ID: 22790862
[TBL] [Abstract][Full Text] [Related]
12. Association between nucleotide excision repair gene polymorphism and colorectal cancer risk.
Zhang Y; Wu S; Zhou X; Huang F; Chen R; Wang Y; Wu J
J Clin Lab Anal; 2019 Oct; 33(8):e22956. PubMed ID: 31568607
[TBL] [Abstract][Full Text] [Related]
13. Xeroderma pigmentosum complementation group C single-nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression-free survival in advanced ovarian cancer.
Fleming ND; Agadjanian H; Nassanian H; Miller CW; Orsulic S; Karlan BY; Walsh CS
Cancer; 2012 Feb; 118(3):689-97. PubMed ID: 21751198
[TBL] [Abstract][Full Text] [Related]
14. From inflammation to colitis-associated colorectal cancer in inflammatory bowel disease: Pathogenesis and impact of current therapies.
Fantini MC; Guadagni I
Dig Liver Dis; 2021 May; 53(5):558-565. PubMed ID: 33541800
[TBL] [Abstract][Full Text] [Related]
15. Genomic characterization of colitis-associated colorectal cancer.
Kameyama H; Nagahashi M; Shimada Y; Tajima Y; Ichikawa H; Nakano M; Sakata J; Kobayashi T; Narayanan S; Takabe K; Wakai T
World J Surg Oncol; 2018 Jul; 16(1):121. PubMed ID: 29966533
[TBL] [Abstract][Full Text] [Related]
16. Colitis-associated neoplasia: molecular basis and clinical translation.
Foersch S; Neurath MF
Cell Mol Life Sci; 2014 Sep; 71(18):3523-35. PubMed ID: 24830703
[TBL] [Abstract][Full Text] [Related]
17. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation.
Itzkowitz SH; Yio X
Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G7-17. PubMed ID: 15194558
[TBL] [Abstract][Full Text] [Related]
18. Role of SMAD proteins in colitis-associated cancer: from known to the unknown.
Chandrasinghe P; Cereser B; Moorghen M; Al Bakir I; Tabassum N; Hart A; Stebbing J; Warusavitarne J
Oncogene; 2018 Jan; 37(1):1-7. PubMed ID: 28869601
[TBL] [Abstract][Full Text] [Related]
19. An alternative cyclin-D1 splice site is not linked to inflammatory bowel disease-associated neoplasia.
Kanaan Z; Eichenberger MR; Young M; Colliver D; Crawford N; Cobbs GA; Hein DW; Galandiuk S
Int J Biol Markers; 2010; 25(1):27-31. PubMed ID: 20306448
[TBL] [Abstract][Full Text] [Related]
20. Stress response protein cirp links inflammation and tumorigenesis in colitis-associated cancer.
Sakurai T; Kashida H; Watanabe T; Hagiwara S; Mizushima T; Iijima H; Nishida N; Higashitsuji H; Fujita J; Kudo M
Cancer Res; 2014 Nov; 74(21):6119-28. PubMed ID: 25187386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
